A single capsule altering the gut microbiome via faecal microbiota transplantation (FMT) showed long-lasting metabolic improvements—potentially reducing diabetes and heart disease risk for years.
A national study suggests that risk factors for cardiovascular disease, such as age, smoking and diabetes are the main contributors to death and poor outcomes for critically ill COVID-19 patients.